These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9848783)

  • 41. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).
    Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP
    Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of 12 novel mutations in the collagenous domain of the COL4A5 gene in Alport syndrome patients.
    Boye E; Flinter F; Zhou J; Tryggvason K; Bobrow M; Harris A
    Hum Mutat; 1995; 5(3):197-204. PubMed ID: 7599631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation in alpha 5(IV) collagen chain gene in nonfamilial hematuria.
    Kitagawa K; Nakanishi K; Iijima K; Nishio H; Sado Y; Sano K; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 1995 Aug; 6(2):264-8. PubMed ID: 7579094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.
    Ueki Y; Naito I; Oohashi T; Sugimoto M; Seki T; Yoshioka H; Sado Y; Sato H; Sawai T; Sasaki F; Matsuoka M; Fukuda S; Ninomiya Y
    Am J Hum Genet; 1998 Feb; 62(2):253-61. PubMed ID: 9463311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the 3' half of the human type IV collagen alpha 5 gene that is affected in the Alport syndrome.
    Zhou J; Hostikka SL; Chow LT; Tryggvason K
    Genomics; 1991 Jan; 9(1):1-9. PubMed ID: 2004755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
    Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
    Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single base pair deletions in exons 39 and 42 of the COL4A5 gene in Alport syndrome.
    Renieri A; Galli L; De Marchi M; Li Volti S; Mollica F; Lupo A; Maschio G; Peissel B; Rossetti S; Pignatti P
    Hum Mol Genet; 1994 Jan; 3(1):201-2. PubMed ID: 8162029
    [No Abstract]   [Full Text] [Related]  

  • 48. Deletions of the COL4A5 gene in patients with Alport syndrome.
    Netzer KO; Renders L; Zhou J; Pullig O; Tryggvason K; Weber M
    Kidney Int; 1992 Dec; 42(6):1336-44. PubMed ID: 1474765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An 8 bp deletion in exon 51 of the COL4A5 gene of an Alport syndrome patient.
    Boye E; Flinter FA; Bobrow M; Harris A
    Hum Mol Genet; 1993 May; 2(5):595-6. PubMed ID: 8518800
    [No Abstract]   [Full Text] [Related]  

  • 50. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
    Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
    Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis.
    Ding J; Zhou J; Tryggvason K; Kashtan CE
    J Am Soc Nephrol; 1994 Aug; 5(2):161-8. PubMed ID: 7993995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
    Wang F; Wang Y; Ding J; Yang J
    Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel Mutations of
    Gong WY; Liu FN; Yin LH; Zhang J
    Biomed Res Int; 2021; 2021():6664973. PubMed ID: 33748275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome.
    Renieri A; Seri M; Myers JC; Pihlajaniemi T; Massella L; Rizzoni G; De Marchi M
    Hum Mol Genet; 1992 May; 1(2):127-9. PubMed ID: 1363780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome.
    Pan X; Yan J; Ren H; Zhang W; Shi H; Yu H; Wang C; Hao C; Chen X; Chen N
    Nephrol Dial Transplant; 2004 May; 19(5):1123-8. PubMed ID: 14993485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel Splicing Mutation Identified in a Chinese Family with X-linked Alport Syndrome Using Targeted Next-Generation Sequencing.
    Chen C; Lu CX; Wang Q; Cao LH; Luo Y; Zhang X
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):203-7. PubMed ID: 26866448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation.
    van der Loop FT; Heidet L; Timmer ED; van den Bosch BJ; Leinonen A; Antignac C; Jefferson JA; Maxwell AP; Monnens LA; Schröder CH; Smeets HJ
    Kidney Int; 2000 Nov; 58(5):1870-5. PubMed ID: 11044206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.